SH2D6 Activators
PMA and Forskolin are instrumental in enhancing the activity of protein kinase C and protein kinase A, respectively. This elevation in kinase activity triggers a cascade of phosphorylation events within the cell that could encompass the SH2D6 protein. Compounds like Okadaic Acid and Lithium Chloride underscore their significance by inhibiting phosphatase enzymes and GSK-3β, thereby tipping the cellular scales towards an environment rich in phosphorylated proteins. This biochemical landscape may inadvertently set the stage for the activation of SH2D6. The diversity in chemical action extends to agents like Epigallocatechin gallate (EGCG) and Anisomycin, which modulate stress-related signaling and activate the JNK pathway, respectively. These modulatory actions can have reverberating effects on the phosphorylation profile of proteins throughout the cell, potentially capturing SH2D6 in their wake.
Calcium signaling also plays a pivotal role, as evidenced by Ionomycin, which, by increasing intracellular calcium levels, impacts calcium-dependent pathways and proteins. The inhibition of key regulatory pathways is another route through which these activators operate. Compounds such as U0126, SB 203580, LY294002, and Rapamycin disrupt the MAPK/ERK, p38 MAP kinase, PI3K, and mTOR pathways, respectively. The inhibition of these pathways does not merely suppress their function but can also provoke the activation of alternative signaling routes that might intersect with those that regulate SH2D6 activity.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is an activator of protein kinase C (PKC) which can influence numerous downstream signaling pathways, potentially leading to the activation of SH2D6 through secondary messengers or phosphorylation events. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
As an inhibitor of protein phosphatases 1 and 2A, Okadaic Acid leads to increased phosphorylation levels within the cell, which can result in the activation of proteins like SH2D6 by preventing their dephosphorylation. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium Chloride inhibits GSK-3β, an enzyme that negatively regulates numerous proteins via phosphorylation. Inhibition of GSK-3β can lead to the upregulation and activation of various proteins, including potentially SH2D6. | ||||||
Spermine | 71-44-3 | sc-212953A sc-212953 sc-212953B sc-212953C | 1 g 5 g 25 g 100 g | $61.00 $196.00 $277.00 $901.00 | 1 | |
Spermine is a polyamine that can modulate various cellular processes, including ion channels and kinases. Through such modulation, spermine can indirectly affect signaling pathways that control the activation state of proteins like SH2D6. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to modulate various signaling pathways, notably those involved in cellular stress responses. Through its effect on these pathways, EGCG can influence the phosphorylation and activation status of proteins, potentially including SH2D6. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates the JNK signaling pathway, which can lead to the phosphorylation of various substrates, thereby influencing other signaling pathways and potentially promoting the activation of SH2D6. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that raises intracellular calcium levels, thereby affecting calcium-dependent signaling pathways. Such pathways can affect the activation of proteins, including potentially SH2D6. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK1/2, which leads to the suppression of the MAPK/ERK pathway. This suppression can result in the compensatory activation of alternative signaling routes that may include pathways regulating SH2D6 activation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
As an inhibitor of p38 MAP kinase, SB 203580 can alter signaling dynamics within the cell, potentially causing the activation of alternative pathways that could regulate the activity of SH2D6. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is an inhibitor of PI3K, which can disrupt PI3K/Akt signaling. This disruption can lead to changes in the activity of downstream proteins and pathways, possibly affecting those that contribute to SH2D6 activation. | ||||||